Dose-dependent induction or depression of cysteine conjugate beta-lyase in rat kidney by N-acetyl-S-(1,2,3,4,4-pentachloro-1,3-butadienyl)-L-cysteine. 1993

M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
Molecular Toxicology Group, School of Biological Sciences, University of Surrey, Guildford, UK.

The influence of N-acetyl-S-(1,2,3,4,4-pentachloro-1,3-butadienyl)-L-cysteine (NAc-PCBD) on cysteine conjugate beta-lyase in female rat kidney has been examined. After a single, non-nephrotoxic dose of NAc-PCBD (3 mg/kg), cytosolic beta-lyase enzyme activity was increased 1.5 to 3-fold commensurate with a corresponding increase in enzyme protein levels as assessed by both Western blot and ELISA analyses. Using a cDNA probe for beta-lyase, this induction was found to be accompanied by an increase in the cognate mRNA. In contrast, a higher, nephrotoxic dose of NAc-PCBD (10 mg/kg) decreased all the above parameters. These effects appeared to be specific to the cytosolic form of the enzyme as no changes in kidney mitochondrial beta-lyase or enzyme protein levels were observed. Repeated dosing with the lower dose level (3 mg/kg) resulted in either no change, or in some instances, a reduction in the above parameters, suggesting an accumulation of the xenobiotic and a masking of the induction phenomenon. The molecular mechanisms underlying these observations are discussed in terms of the nephrotoxicity of halogenated xenobiotics.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008190 Lyases A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. (Enzyme Nomenclature, 1992) EC 4. Desmolase,Desmolases,Lyase
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D002070 Butadienes Four carbon unsaturated hydrocarbons containing two double bonds. Butadiene Derivative,Butadiene Derivatives,Derivative, Butadiene,Derivatives, Butadiene
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme

Related Publications

M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
September 1987, Toxicology and applied pharmacology,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
January 1988, Chemico-biological interactions,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
May 1986, Archives of toxicology,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
January 1988, Chemical research in toxicology,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
March 1982, Molecular pharmacology,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
January 1988, Chemico-biological interactions,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
August 1989, Toxicology and applied pharmacology,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
January 1995, Chemical research in toxicology,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
April 1994, The Journal of pharmacology and experimental therapeutics,
M MacFarlane, and M Schofield, and N Parker, and L Roelandt, and M David, and E A Lock, and L J King, and P S Goldfarb, and G G Gibson
February 1987, Molecular pharmacology,
Copied contents to your clipboard!